10.1016/j.yfrne.2021.100916 Front
However, for people who already had DR, starting a GLP-1 drug didn't make their condition worse
No regulatory body Health Canada, the FDA, the EMA, the TGA, or any equivalent has approved Epithalon as a drug for human or veterinary use
Type 2 diabetes was included as a positive control (107,133 cases, 656,672 controls)
As of July 2025, federal data show hundreds of adverse events tied to compounded or illicit GLP-1s hospitalizations, overdoses and even deaths
It is usually mild and transient, but it can be severe enough to lead some patients to discontinue treatment. MNT also spoke with Mir Ali, MD, a board certified bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA about this study